OAKVILLE, ON, Sept. 25, 2012 /CNW/ - Watson Pharma Company today announced that Rapalfo® (silodosin), a new treatment for benign prostatic hyperplasia (BPH), is available in Canada. BPH is a common, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback